Multiple Sclerosis Treatments Benefit From Discovery of New Inflammatory Molecule
A newly discovered molecule could play a pivotal role in inflammatory diseases, including multiple sclerosis, according to researchers at Trinity…
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
A newly discovered molecule could play a pivotal role in inflammatory diseases, including multiple sclerosis, according to researchers at Trinity…
Dr. Jacob Sosnoff wants to know more about falling — something that few multiple sclerosis (MS) researchers focus on, even though…
A new study suggests that different types of physical activity might help the mental processes of…
A study from German researchers might help to determine how multiple sclerosis is assessed in treatment trials. Published February 6…
Acorda Therapeutics, Inc. has released results from a Phase 1 clinical trial of rHIgM22 for multiple sclerosis, showing…
MediciNova, Inc., has announced the acceptance of an abstract describing their ongoing Phase 2b clinical trial of MN-166 (ibudilast) in progressive multiple…
Biogen Idec, a Cambridge Massachusetts Biotechnology company, has released results from its Phase 2 acute optic neuritis (AON) RENEW…
Human papillomavirus (HPV) vaccination can help protect against several health problems, including cervical cancers in women. Some reports have raised…
A study published on December 22 in JAMA Neurology emphasizes that a standard measurement used to gauge multiple…
Researchers in Spain have found that specific fat stem cells from mice could be excellent tools for studying transplantation…
Have you ever eaten a turkey dinner and afterwards someone says that the feeling of drowsiness is caused by…
Researchers have uncovered new information about myelin, a fatty substance that wraps around the axons of brain cells (neurons)…
Researchers from Canada and the U.S. have found that brains of young people with multiple sclerosis fail to develop…
A team of researchers at the University of California, Riverside, along with other collaborators, have identified a drug associated…
Researchers from the National University of Singapore have found a new type of immune cell that could aid in…
The Oceans of Hope yacht, part of the Sailing Sclerosis Foundation project, has recently arrived in Boston after its…
Fingolimod is a disease modifying therapy (DMT) used to treat relapsing remitting multiple sclerosis (RRMS) patients as…
Biogen Idec, a biotechnology company focused on developing innovative therapies for the treatment of neurodegenerative diseases, hematologic conditions and…
According to a study published in the Journal of Neurology Neurosurgery & Psychiatry, HIV infection is correlated to a…
Synthetic Biologics, Inc., a biotechnology company developing novel drug candidates targeting specific pathogens that cause serious infections and diseases,…
Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute have made encouraging advances in the development of…
The next Bike Multiple Sclerosis Cactus and Crude event, a bike run hosted by the National MS…
The Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis has recently announced the first MENACTRIMS…
A team of researchers from the University of Saint Louis has found a molecular pathway involved in a painful…
Following the promising results of prior trials, Receptos, Inc., a biopharmaceutical company engaged in the treatment of immune and…
A secondary analysis of data from a previous trial of an Internet-based exercise intervention in patients…
Pharmaceutical company Novartis and health tracking and analytics platform Tictrac recently partnered up to support World Multiple Sclerosis Day and raise…
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency recently offered a positive opinion for the marketing authorization…
Although the biological activity by which Copaxone (glatiramer) exerts its effects i multiple sclerosis (MS) patients is not fully understood,…
Marijuana has been approved for medicinal purposes in a number of U.S. states, however it still remains a much…
Get regular updates to your inbox.